Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract.

Wallace JL, Flannigan KL, McKnight W, Wang L, Ferraz JG, Tuitt D.

J Physiol Pharmacol. 2013 Apr;64(2):167-75.

2.

Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain.

Bagüés A, Martín MI, Sánchez-Robles EM.

Eur J Pharmacol. 2014 Dec 15;745:69-75. doi: 10.1016/j.ejphar.2014.10.016. Epub 2014 Oct 19.

PMID:
25446925
3.

Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346).

Wallace JL, Caliendo G, Santagada V, Cirino G.

Br J Pharmacol. 2010 Mar;159(6):1236-46. doi: 10.1111/j.1476-5381.2009.00611.x. Epub 2010 Feb 1.

4.

Cannabinoids in acute gastric damage and pancreatitis.

Dembiński A, Warzecha Z, Ceranowicz P, Dembiński M, Cieszkowski J, Pawlik WW, Konturek SJ, Tomaszewska R, Hładki W, Konturek PC.

J Physiol Pharmacol. 2006 Nov;57 Suppl 5:137-54.

PMID:
17218765
5.

Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.

DeLong GT, Wolf CE, Poklis A, Lichtman AH.

Drug Alcohol Depend. 2010 Nov 1;112(1-2):126-33. doi: 10.1016/j.drugalcdep.2010.05.019.

6.

The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.

Abalo R, Cabezos PA, Vera G, Fernández-Pujol R, Martín MI.

Neurogastroenterol Motil. 2010 Jun;22(6):694-e206. doi: 10.1111/j.1365-2982.2009.01466.x. Epub 2010 Feb 3.

PMID:
20132133
7.

Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.

Booker L, Naidu PS, Razdan RK, Mahadevan A, Lichtman AH.

Drug Alcohol Depend. 2009 Nov 1;105(1-2):42-7. doi: 10.1016/j.drugalcdep.2009.06.009. Epub 2009 Aug 12.

8.

The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.

Cox ML, Haller VL, Welch SP.

Eur J Pharmacol. 2007 Sep 10;570(1-3):50-6. Epub 2007 Jun 5.

PMID:
17588560
9.

Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats.

Ting CH, Chi CW, Li CP, Chen CY.

Nutrition. 2015 Jan;31(1):230-5. doi: 10.1016/j.nut.2014.06.008. Epub 2014 Jul 5.

PMID:
25466669
10.

Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damage.

Fomenko I, Sklyarov A, Bondarchuk T, Biletska L, Panasyuk N, Wallace JL.

Stress. 2014 Dec;17(6):528-37. doi: 10.3109/10253890.2014.967207.

PMID:
25238023
11.

The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.

da Fonseca Pacheco D, Klein A, de Castro Perez A, da Fonseca Pacheco CM, de Francischi JN, Duarte ID.

Br J Pharmacol. 2008 Jul;154(5):1143-9. doi: 10.1038/bjp.2008.175. Epub 2008 May 12.

12.

Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.

Abalo R, Cabezos PA, Vera G, López-Miranda V, Herradón E, Martín-Fontelles MI.

Neurogastroenterol Motil. 2011 May;23(5):457-67, e177. doi: 10.1111/j.1365-2982.2011.01677.x. Epub 2011 Feb 8.

PMID:
21303434
13.

Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.

Järbe TU, Liu Q, Makriyannis A.

Psychopharmacology (Berl). 2006 Jan;184(1):36-45. Epub 2005 Nov 24.

PMID:
16307294
14.

Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors.

Fichna J, Dicay M, Lewellyn K, Janecka A, Zjawiony JK, MacNaughton WK, Storr MA.

Inflamm Bowel Dis. 2012 Jun;18(6):1137-45. doi: 10.1002/ibd.21873. Epub 2011 Sep 26.

PMID:
21953882
15.

Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation.

Alhouayek M, Lambert DM, Delzenne NM, Cani PD, Muccioli GG.

FASEB J. 2011 Aug;25(8):2711-21. doi: 10.1096/fj.10-176602. Epub 2011 May 6.

PMID:
21551239
16.

Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.

Mulè F, Amato A, Baldassano S, Serio R.

Pharmacol Res. 2007 Sep;56(3):185-92. Epub 2007 Jun 21.

PMID:
17656103
17.

Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.

Brzozowski T, Konturek PC, Konturek SJ, Sliwowski Z, Drozdowicz D, Kwiecień S, Pajdo R, Ptak A, Pawlik M, Hahn E.

Dig Liver Dis. 2000 Oct;32(7):583-94.

PMID:
11142556
18.

Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.

Romero TR, Pacheco Dda F, Duarte ID.

Life Sci. 2013 May 2;92(14-16):815-20. doi: 10.1016/j.lfs.2012.10.006. Epub 2012 Oct 30.

PMID:
23123446
19.

Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats.

Chen L, Zhang J, Li F, Qiu Y, Wang L, Li YH, Shi J, Pan HL, Li M.

J Pain. 2009 Jul;10(7):732-9. doi: 10.1016/j.jpain.2008.12.012. Epub 2009 May 5.

PMID:
19409856
20.

Anti-inflammatory and cytoprotective properties of hydrogen sulfide.

Gemici B, Wallace JL.

Methods Enzymol. 2015;555:169-93. doi: 10.1016/bs.mie.2014.11.034. Epub 2015 Jan 8.

PMID:
25747480

Supplemental Content

Support Center